Home » Topics » Regulatory » Patents

Patents
RSS

Scientists at Cell Therapeutics disclose new signal transduction inhibitors

Oct. 16, 1998

Israeli investigators disclose novel series of neuroprotective compounds

Oct. 15, 1998

Knoll claims another series of heteroarylsulfonamide compounds for CNS and other disorders

Oct. 15, 1998

Japanese laboratory synthesizes new antidiabetic agents

Oct. 15, 1998

Heterocyclic anticoagulants in development at BioChem Pharma

Oct. 15, 1998

Modulators of neurotransmitter function claimed by Hoechst Marion Roussel for depression, PD

Oct. 15, 1998

Novel Lp(a)-lowering agents prepared by SKB-Symphar team

Oct. 15, 1998

Roche presents series of OFQ (ORL1) receptor agonists/antagonists

Oct. 14, 1998

Immunomodulating thalidomide analogues patented by Gruenenthal

Oct. 14, 1998

Bicyclic inhibitors of protein farnesyltransferase for cancer, restenosis, etc.

Oct. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 27, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 27, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...